{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:34:16Z","timestamp":1790087656687,"version":"4.0.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7222093"],"award-info":[{"award-number":["7222093"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Capital Clinical Diagnostic Techniques and Translational Application Projects","award":["Z211100002921059"],"award-info":[{"award-number":["Z211100002921059"]}]},{"name":"National Key Research and Development Program of Ministry of Science and Technology","award":["2023YFC2308100"],"award-info":[{"award-number":["2023YFC2308100"]}]},{"name":"High-level Public Health Technical Talents Construction Project of Beijing Municipal Health Commission","award":["Academic Leader-02-14"],"award-info":[{"award-number":["Academic Leader-02-14"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-03012-1","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T04:22:09Z","timestamp":1763871729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Machine learning model for HBsAg seroclearance after 48-week pegylated interferon therapy in inactive HBsAg carriers: a retrospective study"],"prefix":"10.1186","volume":"23","author":[{"given":"Jianxia","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junliang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiliang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingliang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfa","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,23]]},"reference":[{"key":"3012_CR1","unstructured":"Organization WH. WHO sounds alarm on viral hepatitis infections claiming 3500 lives each day. 2024. https:\/\/www.who.int\/news\/item\/09-04-2024-who-sounds-alarm-on-viral-hepatitis-infections-claiming-3500-lives-each-day"},{"issue":"4","key":"3012_CR2","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology Apr. 2018;67(4):1560\u201399. https:\/\/doi.org\/10.1002\/hep.29800.","journal-title":"Hepatology Apr"},{"issue":"1","key":"3012_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00535-016-1229-6","volume":"52","author":"T Taida","year":"2017","unstructured":"Taida T, Arai M, Kanda T, et al. The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study. J Gastroenterol. 2017;52(1):113\u201322. https:\/\/doi.org\/10.1007\/s00535-016-1229-6.","journal-title":"J Gastroenterol"},{"key":"3012_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.11604\/pamj.2018.31.49.16296","volume":"31","author":"I Diallo","year":"2018","unstructured":"Diallo I, Ndiaye B, Fall CA, et al. Inactive hepatitis B carriers: outcomes of patients followed at H\u00f4pital principal de Dakar, Senegal. Pan Afr Med J. 2018;31:49. https:\/\/doi.org\/10.11604\/pamj.2018.31.49.16296.","journal-title":"Pan Afr Med J"},{"key":"3012_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.779347","volume":"12","author":"A Song","year":"2021","unstructured":"Song A, Lin X, Lu J, et al. Pegylated interferon treatment for the effective clearance of hepatitis B surface antigen in inactive HBsAg carriers: a meta-analysis. Front Immunol. 2021;12:779347. https:\/\/doi.org\/10.3389\/fimmu.2021.779347.","journal-title":"Front Immunol"},{"issue":"9","key":"3012_CR6","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1111\/liv.14897","volume":"41","author":"F Wu","year":"2021","unstructured":"Wu F, Lu R, Liu Y, et al. Efficacy and safety of peginterferon alpha monotherapy in Chinese inactive chronic hepatitis B virus carriers. Liver Int. 2021;41(9):2032\u201345. https:\/\/doi.org\/10.1111\/liv.14897.","journal-title":"Liver Int"},{"issue":"4","key":"3012_CR7","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s40121-021-00511-w","volume":"10","author":"Y Huang","year":"2021","unstructured":"Huang Y, Qi M, Liao C, et al. Analysis of the efficacy and safety of pegylated interferon-\u03b12b treatment in inactive hepatitis B surface antigen carriers. Infect Dis Ther. 2021;10(4):2323\u201331. https:\/\/doi.org\/10.1007\/s40121-021-00511-w.","journal-title":"Infect Dis Ther"},{"issue":"4","key":"3012_CR8","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1007\/s12072-024-10666-6","volume":"18","author":"PX Zhang","year":"2024","unstructured":"Zhang PX, Tang QQ, Zhu J, Deng WY, Zhang ZH. Predictive models for functional cure in patients with CHB receiving PEG-IFN therapy based on HBsAg quantification through meta-analysis. Hepatol Int. 2024;18(4):1110\u201321. https:\/\/doi.org\/10.1007\/s12072-024-10666-6.","journal-title":"Hepatol Int"},{"key":"3012_CR9","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.12659\/msm.916441","volume":"23","author":"Q Chen","year":"2019","unstructured":"Chen Q, Zhang J, Huang J, et al. Early serum HBsAg drop is a strong predictor of hbeag seroconversion and HBsAg loss to pegylated interferon Alfa-2a in chronic hepatitis B patients with prior Nucleos(t)ide analogue exposure. Med Sci Monit Jun. 2019;23:25:4665\u201374. https:\/\/doi.org\/10.12659\/msm.916441.","journal-title":"Med Sci Monit Jun"},{"issue":"13","key":"3012_CR10","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3748\/wjg.v26.i13.1525","volume":"7","author":"FP Wu","year":"2020","unstructured":"Wu FP, Yang Y, Li M. Add-on pegylated interferon augments hepatitis B surface antigen clearance vs continuous nucleos(t)ide analog monotherapy in Chinese patients with chronic hepatitis B and hepatitis B surface antigen \u2264 1500 IU\/mL: an observational study. World J Gastroenterol. 2020;7(13):1525\u201339. https:\/\/doi.org\/10.3748\/wjg.v26.i13.1525.","journal-title":"World J Gastroenterol"},{"issue":"13","key":"3012_CR11","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMra2302038","volume":"30","author":"CJ Haug","year":"2023","unstructured":"Haug CJ, Drazen JM. Artificial intelligence and machine learning in clinical medicine, 2023. N Engl J Med. 2023;30(13):1201\u20138. https:\/\/doi.org\/10.1056\/NEJMra2302038.","journal-title":"N Engl J Med"},{"key":"3012_CR12","doi-asserted-by":"publisher","unstructured":"[The guidelines of prevention and treatment for chronic hepatitis B. (2019 version)]. Zhonghua Gan Zang Bing Za Zhi. Dec 20 2019;27(12):938\u2013961. https:\/\/doi.org\/10.3760\/cma.j.issn.1007-3418.2019.12.007","DOI":"10.3760\/cma.j.issn.1007-3418.2019.12.007"},{"key":"3012_CR13","doi-asserted-by":"publisher","unstructured":"EASL. 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. Aug 2017;67(2):370\u2013398. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.021","DOI":"10.1016\/j.jhep.2017.03.021"},{"issue":"4","key":"3012_CR14","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/hep.29213","volume":"66","author":"Z Cao","year":"2017","unstructured":"Cao Z, Liu Y, Ma L, et al. A potent hepatitis B surface antigen response in subjects with inactive hepatitis B surface antigen carrier treated with pegylated-interferon alpha. Hepatology. 2017;66(4):1058\u201366. https:\/\/doi.org\/10.1002\/hep.29213.","journal-title":"Hepatology"},{"issue":"6","key":"3012_CR15","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.14218\/jcth.2023.00320","volume":"28","author":"H You","year":"2023","unstructured":"You H, Wang F, Li T, et al. Guidelines for the prevention and treatment of chronic hepatitis B (version 2022). J Clin Transl Hepatol Nov. 2023;28(6):1425\u201342. https:\/\/doi.org\/10.14218\/jcth.2023.00320.","journal-title":"J Clin Transl Hepatol Nov"},{"key":"3012_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.997608","volume":"13","author":"X Yang","year":"2022","unstructured":"Yang X, Zhang K, Xu Q, et al. Interferon add-on therapy increased clinical cure significantly for interferon-experienced chronic hepatitis B patients with low HBsAg. Front Immunol. 2022;13:997608. https:\/\/doi.org\/10.3389\/fimmu.2022.997608.","journal-title":"Front Immunol"},{"issue":"2","key":"3012_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jhep.2020.04.013","volume":"73","author":"I Tout","year":"2020","unstructured":"Tout I, Loureiro D, Mansouri A, Soumelis V, Boyer N, Asselah T. Hepatitis B surface antigen seroclearance: immune mechanisms, clinical impact, importance for drug development. J Hepatol. 2020;73(2):409\u201322. https:\/\/doi.org\/10.1016\/j.jhep.2020.04.013.","journal-title":"J Hepatol"},{"issue":"1","key":"3012_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jhep.2024.02.017","volume":"81","author":"BC Narmada","year":"2024","unstructured":"Narmada BC, Khakpoor A, Shirgaonkar N, et al. Single-cell landscape of functionally cured chronic hepatitis B patients reveals activation of innate and altered CD4-CTL-driven adaptive immunity. J Hepatol. 2024;81(1):42\u201361. https:\/\/doi.org\/10.1016\/j.jhep.2024.02.017.","journal-title":"J Hepatol"},{"issue":"5","key":"3012_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29627","volume":"96","author":"L Wu","year":"2024","unstructured":"Wu L, Deng H, Feng X, et al. Interferon-\u03b3(+) Th1 activates intrahepatic resident memory T cells to promote HBsAg loss by inducing M1 macrophage polarization. J Med Virol. 2024;96(5):e29627. https:\/\/doi.org\/10.1002\/jmv.29627.","journal-title":"J Med Virol"},{"issue":"1","key":"3012_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jhep.2019.08.024","volume":"72","author":"H Wang","year":"2020","unstructured":"Wang H, Luo H, Wan X, et al. TNF-\u03b1\/IFN-\u03b3 profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection. J Hepatol. 2020;72(1):45\u201356. https:\/\/doi.org\/10.1016\/j.jhep.2019.08.024.","journal-title":"J Hepatol"},{"issue":"20","key":"3012_CR21","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1161\/circulationaha.115.001593","volume":"17","author":"RC Deo","year":"2015","unstructured":"Deo RC. Machine learning in medicine. Circulation. 2015;17(20):1920\u201330. https:\/\/doi.org\/10.1161\/circulationaha.115.001593.","journal-title":"Circulation"},{"issue":"16","key":"3012_CR22","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1161\/circulationaha.120.050583","volume":"20","author":"RC Deo","year":"2020","unstructured":"Deo RC. Machine learning in medicine. Circulation. 2020;20(16):1521\u20133. https:\/\/doi.org\/10.1161\/circulationaha.120.050583.","journal-title":"Circulation"},{"issue":"Suppl","key":"3012_CR23","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.3350\/cmh.2024.0780","volume":"31","author":"D Wu","year":"2025","unstructured":"Wu D, Kao JH, Piratvisuth T, et al. Update on the treatment navigation for functional cure of chronic hepatitis B: expert consensus 2.0. Clin Mol Hepatol Feb. 2025;31(Suppl):S134\u201364. https:\/\/doi.org\/10.3350\/cmh.2024.0780.","journal-title":"Clin Mol Hepatol Feb"},{"key":"3012_CR24","doi-asserted-by":"publisher","unstructured":"Jeng WJ, Papatheodoridis GV, Lok ASF. Hepatitis B. Lancet. 2023(10381). https:\/\/doi.org\/10.1016\/s0140-6736(22)01468-4.","DOI":"10.1016\/s0140-6736(22)01468-4"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-03012-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-03012-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-03012-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:02:51Z","timestamp":1767834171000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12985-025-03012-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3012"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-03012-1","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,23]]},"assertion":[{"value":"3 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants prior to data collection. As this study involved a retrospective analysis of prospectively collected clinical data, the use of patient information was reviewed and approved by the institutional review boards of the participating centers in accordance with the ethical standards of the Declaration of Helsinki. Ethical approval was obtained from the institutional review boards of all participating centers (Primary cohort: 2022-067-K; External cohort: 2022-047-K).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We give our consent for information about our relative (circle as appropriate) to be published in Virology Journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}